Skandinaviska Enskilda Banken (SEB)’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-48,785
| Closed | -$4.39M | – | 715 |
|
|
2025
Q4 | $4.39M | Sell |
48,785
-13,294
| -21% | -$1.26M | 0.02% | 446 |
|
|
2025
Q3 | $6.11M | Buy |
62,079
+19,996
| +48% | +$1.98M | 0.02% | 377 |
|
|
2025
Q2 | $3.84M | Hold |
42,083
| – | – | 0.02% | 469 |
|
|
2025
Q1 | $4.76M | Sell |
42,083
-1,000
| -2% | -$107K | 0.02% | 427 |
|
|
2024
Q4 | $4.54M | Hold |
43,083
| – | – | 0.02% | 431 |
|
|
2024
Q3 | $4.65M | Hold |
43,083
| – | – | 0.02% | 422 |
|
|
2024
Q2 | $4.68M | Hold |
43,083
| – | – | 0.02% | 393 |
|
|
2024
Q1 | $5.69M | Sell |
43,083
-2,500
| -5% | -$312K | 0.03% | 378 |
|
|
2023
Q4 | $5.55M | Sell |
45,583
-4,382
| -9% | -$489K | 0.03% | 366 |
|
|
2023
Q3 | $5.61M | Sell |
49,965
-7,652
| -13% | -$972K | 0.04% | 342 |
|
|
2023
Q2 | $8.39M | Sell |
57,617
-9,894
| -15% | -$1.34M | 0.06% | 289 |
|
|
2023
Q1 | $8.72M | Sell |
67,511
-50,388
| -43% | -$6.33M | 0.06% | 282 |
|
|
2022
Q4 | $15M | Buy |
117,899
+11,223
| +11% | +$1.3M | 0.11% | 196 |
|
|
2022
Q3 | $11.2M | Buy |
106,676
+48,350
| +83% | +$5.31M | 0.09% | 223 |
|
|
2022
Q2 | $6.13M | Sell |
58,326
-32,844
| -36% | -$3.9M | 0.05% | 324 |
|
|
2022
Q1 | $11.7M | Sell |
91,170
-67,793
| -43% | -$8.17M | 0.07% | 249 |
|
|
2021
Q4 | $19.8M | Sell |
158,963
-118,288
| -43% | -$15.5M | 0.1% | 183 |
|
|
2021
Q3 | $39.4M | Sell |
277,251
-54,681
| -16% | -$8.04M | 0.22% | 103 |
|
|
2021
Q2 | $51.8M | Buy |
331,932
+24,774
| +8% | +$4.01M | 0.32% | 72 |
|
|
2021
Q1 | $47.7M | Buy |
307,158
+132,123
| +75% | +$20.5M | 0.31% | 70 |
|
|
2020
Q4 | $26.2M | Buy |
175,035
+14,644
| +9% | +$2.07M | 0.18% | 124 |
|
|
2020
Q3 | $21.2M | Buy |
160,391
+7,330
| +5% | +$958K | 0.15% | 136 |
|
|
2020
Q2 | $17.7M | Buy |
153,061
+22,541
| +17% | +$2.6M | 0.14% | 140 |
|
|
2020
Q1 | $12.8M | Buy |
130,520
+91,587
| +235% | +$12M | 0.13% | 152 |
|
|
2019
Q4 | $5.66M | Buy |
38,933
+3,914
| +11% | +$540K | 0.04% | 303 |
|
|
2019
Q3 | $4.67M | Sell |
35,019
-1,957
| -5% | -$253K | 0.04% | 332 |
|
|
2019
Q2 | $4.23M | Buy |
36,976
+515
| +1% | +$60.3K | 0.04% | 347 |
|
|
2019
Q1 | $4.52M | Buy |
36,461
+1,545
| +4% | +$176K | 0.04% | 304 |
|
|
2018
Q4 | $3.52M | Sell |
34,916
-1,031
| -3% | -$116K | 0.03% | 340 |
|
|
2018
Q3 | $4.59M | Sell |
35,947
-2,369
| -6% | -$282K | 0.03% | 310 |
|
|
2018
Q2 | $4.15M | Buy |
38,316
+12,773
| +50% | +$1.39M | 0.04% | 305 |
|
|
2018
Q1 | $2.7M | Sell |
25,543
-14,833
| -37% | -$1.72M | 0.03% | 320 |
|
|
2017
Q4 | $4.73M | Buy |
40,376
+3,812
| +10% | +$431K | 0.04% | 289 |
|
|
2017
Q3 | $4.16M | Buy |
36,564
+1,854
| +5% | +$214K | 0.04% | 328 |
|
|
2017
Q2 | $4.33M | Buy |
34,710
+103
| +0.3% | +$12.2K | 0.04% | 321 |
|
|
2017
Q1 | $4.1M | Sell |
34,607
-1,667
| -5% | -$189K | 0.04% | 317 |
|
|
2016
Q4 | $3.63M | Buy |
36,274
+1,566
| +5% | +$168K | 0.04% | 285 |
|
|
2016
Q3 | $4.38M | Buy |
34,708
+721
| +2% | +$89.1K | 0.05% | 281 |
|
|
2016
Q2 | $3.97M | Buy |
33,987
+7,828
| +30% | +$886K | 0.04% | 291 |
|
|
2016
Q1 | $2.71M | Sell |
26,159
-824
| -3% | -$79.7K | 0.03% | 353 |
|
|
2015
Q4 | $2.69M | Buy |
+26,983
| New | +$2.64M | 0.03% | 316 |
|
Other funds holding ZBH
Skandinaviska Enskilda Banken (SEB)'s ZBH Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 48,785 shares — an estimated $4.39M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in ZBH in Q4 2015 and held it in 41 quarters. The position peaked at $51.8M in Q2 2021. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 48,785 Zimmer Biomet shares in Q1 2026, an estimated $4.39M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Zimmer Biomet in Q4 2015 and held it in 41 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Zimmer Biomet position peaked at $51.8M in Q2 2021.
- 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.